Details for Patent: 8,906,887
✉ Email this page to a colleague
Which drugs does patent 8,906,887 protect, and when does it expire?
Patent 8,906,887 protects XERAVA and is included in one NDA.
This patent has seventy-two patent family members in thirty-one countries.
Summary for Patent: 8,906,887
| Title: | C7-fluoro substituted tetracycline compounds |
| Abstract: | The present invention is directed to a compound represented by Structural Formula (A): ##STR00001## or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (A) and its therapeutic use. |
| Inventor(s): | Zhou; Jingye (Belmont, MA), Xiao; Xiao-Yi (San Diego, CA), Plamondon; Louis (Belmont, MA), Hunt; Diana Katharine (Cambridge, MA), Clark; Roger B. (Lexington, MA), Zahler; Robert B. (Pennington, NJ) |
| Assignee: | Tetraphase Pharmaceuticals, Inc. (Watertown, MA) |
| Application Number: | 12/462,795 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; |
Drugs Protected by US Patent 8,906,887
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tetraphase Pharms | XERAVA | eravacycline dihydrochloride | POWDER;INTRAVENOUS | 211109-001 | Aug 27, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Tetraphase Pharms | XERAVA | eravacycline dihydrochloride | POWDER;INTRAVENOUS | 211109-002 | Jun 3, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,906,887
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2323972 | ⤷ Sign Up | 300971 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2323972 | ⤷ Sign Up | 122019000024 | Germany | ⤷ Sign Up |
| European Patent Office | 2323972 | ⤷ Sign Up | PA2019009 | Lithuania | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
